New hope for endometrial cancer: drug combo shows promise
NCT ID NCT06746116
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a combination of drugs (durvalumab, chemotherapy, and olaparib) as a first treatment for people with advanced or recurrent endometrial cancer that has a specific genetic marker (pMMR). The goal is to see how safe and tolerable the treatment is. About 85 people in Spain will take part, and they will be followed for up to 3 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR RECURRENT ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
A Coruña, 15006, Spain
-
Research Site
Alicante, 03010, Spain
-
Research Site
Barakaldo, 48903, Spain
-
Research Site
Barcelona, 08035, Spain
-
Research Site
Córdoba, 14004, Spain
-
Research Site
El Palmar, 30120, Spain
-
Research Site
Girona, 17007, Spain
-
Research Site
L'Hospitalet de Llobregat, 08908, Spain
-
Research Site
Las Palmas de Gran Canaria, 35016, Spain
-
Research Site
Madrid, 28034, Spain
-
Research Site
Madrid, 28041, Spain
-
Research Site
Madrid, 28046, Spain
-
Research Site
Madrid, 28807, Spain
-
Research Site
Málaga, 29010, Spain
-
Research Site
Pamplona, 31008, Spain
-
Research Site
Salamanca, 37007, Spain
-
Research Site
San Sebastián, 20014, Spain
-
Research Site
Santander, 39008, Spain
-
Research Site
Seville, 41013, Spain
-
Research Site
Valencia, 46009, Spain
-
Research Site
Valencia, 46010, Spain
-
Research Site
Valencia, 46026, Spain
-
Research Site
Vigo, 36312, Spain
-
Research Site
Zaragoza, 50009, Spain